中机认检 reported revenue of ¥0.44B for the period ended 2026-06-30, +12.6% year on year. Net income was ¥0.09B, a 19.9% net margin on a 45.3% gross margin. The largest revenue line is 检测业务 at 74% of the total. Free cash flow for the period was ¥0.04B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.44B | +12.6% |
| Gross profit | ¥0.20B | — |
| Operating income | ¥0.10B | — |
| Net income | ¥0.09B | +19.1% |
| Gross margin | 45.3% | Net margin 19.9% |
| Revenue Q/Q | +29.9% | — |
| Segment | Revenue | Share |
|---|---|---|
| 检测业务 | ¥0.32B | 74.3% |
| 认证业务 | ¥0.09B | 20.5% |
| 汽车设计 | ¥0.01B | 3.1% |
| 其他(补充) | ¥0.01B | 2.1% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.24B | 54.7% |
| R&D | ¥0.04B | 8.5% |
| SG&A | ¥0.06B | 13.0% |
| Tax & other | ¥0.02B | 3.5% |
| Item | Amount |
|---|---|
| Total assets | ¥2.93B |
| Total liabilities | ¥0.65B |
| Shareholders' equity | ¥2.28B |
| Equity / assets | 77.7% |
| Operating cash flow | ¥0.07B |
| Capital expenditure | ¥0.03B |
| Free cash flow | ¥0.04B |
| Cash conversion (OCF / net income) | 158% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
金凯生科 ・ 固高科技 ・ 德福科技 ・ 智信精密 ・ 尚水智能 ・ 港通医疗 ・ 中远通 ・ 陕西华达 ・ 长华化学 ・ 舜禹股份 ・ 万邦医药 ・ 上大股份
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies